iPSCs : Recent Clinical Insights & Progress

iPSCs : Recent Clinical Insights & Progress

12 – 13 Nov 2026 | Paris, France

Register
Register
Register

12 November 2026 - 13 November 2026

75015 Paris, France

16, rue Jean Rey

UIC-P Espaces Congrès

iPSCs : Recent Clinical Insights & Progress

Registration open until 13 Nov 2026

🧬 iPSC-Derived Cell Therapies Symposium

Advancing the Future of Regenerative Medicine 🚀

We are entering an extraordinary era for regenerative medicine — one where iPSC-derived cell therapies hold the potential to transform the treatment of some of the world’s most challenging diseases. 

This symposium will bring together a dynamic international community of scientists, clinicians, biotech leaders, manufacturers, regulators, and innovators dedicated to accelerating the development of transformative therapies for patients. 

________________________________________________________________________________________________

📖 Program Overview

The development of induced pluripotent stem cell (iPSC)-derived therapies is opening exciting new opportunities to create innovative — and potentially curative — treatments for diseases with limited or no therapeutic options. 

As some of the most advanced therapies in modern medicine, these disruptive technologies also bring significant scientific, regulatory, manufacturing, and clinical challenges linked to the complexity of biological products. 

This symposium adopts a unique patient-centered approach, starting with the desired clinical outcome and working backward to optimize every stage of development. 

________________________________________________________________________________________________

🔄 From “Bedside Back to Bench”

Unlike traditional scientific meetings based on the classic “bench-to-bedside” pathway, this program takes a reverse-development perspective. 

We begin with the ultimate goal:

  • ✅ Safe therapies
  • ✅ Effective clinical outcomes
  • ✅ Successful and scalable cell therapy products

Using this framework, the symposium explores how discovery, translational science, manufacturing, regulatory strategy, and clinical development can be aligned to accelerate patient access to next-generation therapies. 

________________________________________________________________________________________________

🌟 Why Attend?

  • ✨ Discover the latest advances in iPSC-derived therapies
  • 🤝 Network with leading international experts and innovators
  • 🧠 Gain strategic insights into translational and clinical development
  • 🏭 Explore manufacturing, scalability, and regulatory challenges
  • 💼 Connect with key stakeholders across academia and industry

________________________________________________________________________________________________

👥 Who Should Attend?

This symposium is designed for academic and industry professionals involved in the development of iPSC-derived cell therapies at all stages, including:

  • 🔬 Researchers & Clinicians
  • 📋 Regulatory Professionals
  • 🏭 Manufacturers & CDMOs
  • 🧪 Preclinical & Clinical Trial Experts
  • 📊 CROs & Service Providers
  • 💡 Investors & Innovators

Join the community shaping the future of regenerative medicine and help turn scientific breakthroughs into life-changing therapies. 

KEYNOTE Speakers confirmed

Prof. Dan S. Kaufman

Professor, Department of Medicine
Co-director of **Sanford Stem Cell Institute
**San Diego, USA
Endowed Chair Director,
Cell Therapy Program
Sanford Advanced Therapy Center

Prof. Deepak Srivastava

Professor of Pediatrics and of Biochemistry & Biophysics,
University of California, San Francisco (UCSF) Medical Center, USA
President of Gladstone Institutes
Director of Roddenberry Stem Cell Center at Gladstone

Prof. Jihwan Song

Professor, Department of Biomedical Science,
CHA University,
President of Korean Society for Stem Cell Research
Founder & CEO iPS Bio, Inc., South Korea

Prof. Keiichi Fukuda

Chief Executive Officer
Heartseed Inc., Tokyo, Japan
Representative Director of the Board

Prof. Hongkui Deng

Boya Chair Professor of Cell Biology,
**Peking University Health Science Center
**School of Basic Medical Sciences
Director of Peking University Stem Cell Research Center, China

Dr. Alex NG

Chief Innovation Officer & Co-founder
GC Therapeutics, USA

Organizers

CiTHERA
Vaincre Le Cancer